Insider Trading April 3, 2026

Teradyne President Executes Stock Sales as Company Rolls Out New Test Platforms

Regan Mills sold shares under a pre-arranged plan while Teradyne advances manufacturing test offerings and draws mixed analyst attention

By Marcus Reed TER
Teradyne President Executes Stock Sales as Company Rolls Out New Test Platforms
TER

Regan Mills, President of Product Test at Teradyne (NASDAQ: TER), sold 252 shares on April 2, 2026, for $73,301 and had 222 shares withheld on April 1, 2026, to cover taxes tied to RSU vesting. The transactions were conducted under a Rule 10b5-1 trading plan. Teradyne recently unveiled two automated test platforms and drew analyst target increases even as one valuation assessment flags the stock as potentially overvalued.

Key Points

  • Regan Mills sold 252 shares on April 2, 2026, for $73,301 at $290.88 per share and had 222 shares withheld on April 1, 2026, worth $69,308 at $312.20 per share to cover RSU taxes.
  • Sales were executed under a pre-arranged Rule 10b5-1 trading plan; Mills now directly owns 11,415.3452 Teradyne shares.
  • Teradyne launched the Photon 100 for silicon photonics and co-packaged optics testing and Omnyx for PCB assembly testing aimed at AI and data center applications; analysts raised price targets amid mixed valuation signals.

Regan Mills, who serves as President, Product Test at Teradyne (NASDAQ: TER), reported two recent transactions that reduced her direct stake in the company. A Form 4 filed with the Securities and Exchange Commission shows Mills sold 252 shares of Teradyne common stock on April 2, 2026, for a total of $73,301, at a price of $290.88 per share.

The filing also records that on April 1, 2026, Teradyne withheld 222 shares from Mills to satisfy tax obligations arising from the vesting of restricted stock units. Those 222 shares were recorded at $312.20 per share and valued at $69,308.

Both transactions were executed under a pre-arranged trading plan intended to comply with Rule 10b5-1. Following these dispositions, Mills directly holds 11,415.3452 shares of Teradyne.

Market context for the stock is notable. Teradyne shares are trading at $309.61, a price that reflects a 314% return over the past 12 months and a 113% gain in the last six months. An InvestingPro assessment cited in the filings indicates the company appears overvalued on its Fair Value metric, and notes a price-to-earnings ratio of 88.68.

Operationally, Teradyne has been active in product introductions. The company announced two new platforms designed to bolster manufacturing test capabilities. The Photon 100 is described as an automated test platform for silicon photonics and co-packaged optics manufacturing, aimed at supporting high-volume production environments. Separately, Teradyne launched Omnyx, a test platform focused on printed circuit board assemblies and sub-assemblies, with an emphasis on applications tied to artificial intelligence and data center usage. Both platforms are presented as integrating advanced testing features to address manufacturing challenges.

Analyst coverage and outlooks have shifted alongside these product developments. Aletheia published a positive outlook on Teradyne stock, pointing to a recovery in Taiwan's tester imports that they attribute to sizeable orders from KYEC. Morgan Stanley raised its price target for Teradyne to $306 while maintaining an Equalweight rating, citing stronger networking growth forecasts. Cantor Fitzgerald lifted its price target to $330 and highlighted Teradyne's strategic shift toward artificial intelligence, noting that AI now makes up a significant portion of the company's revenue.

These corporate updates, analyst adjustments, and insider transactions together paint a picture of a company in active transition. The filings provide a detailed record of Mills' share movements and disclose the framework - a Rule 10b5-1 plan - under which the sales were made.


Disclosure

Risks

  • Valuation concern: An InvestingPro Fair Value assessment flagged Teradyne as appearing overvalued, with a P/E ratio of 88.68 - a factor that may influence investor decisions in the semiconductor and technology equipment sectors.
  • Insider transactions: While the sales were conducted under a pre-arranged Rule 10b5-1 plan, the reported dispositions could affect market perception and investor sentiment toward Teradyne stock.
  • Analyst divergence: Despite several firms increasing price targets, differing analyst views and reliance on AI-related revenue shifts introduce uncertainty for investors evaluating the company within semiconductor, manufacturing test equipment, and data center markets.

More from Insider Trading

Teladoc Accounting Chief Disposes of 675 Shares Following Option Exercise Apr 3, 2026 Monolithic Power Executive Sells $33,493 in Stock; Holds Remains Substantial Apr 3, 2026 Moody's CEO Disposes $382,662 of MCO Shares; Option Exercises Also Executed Apr 3, 2026 Regeneron Director Executes $77,727 Stock Sale as Company Advances Clinical and Data Initiatives Apr 3, 2026 Avalo Therapeutics CFO Sells $270,593 in Stock Under Prearranged Plan Apr 3, 2026